Henry W Lim

Summary

Affiliation: Henry Ford Hospital
Country: USA

Publications

  1. ncbi Remembrance: Irwin Freedberg
    Henry W Lim
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
    J Invest Dermatol 126:522. 2006
  2. ncbi Sunlight, tanning booths, and vitamin D
    Henry W Lim
    Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 52:868-76. 2005
  3. ncbi Commentary: A responsible approach to maintaining adequate serum vitamin D levels
    Henry W Lim
    Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 57:594-5. 2007
  4. ncbi Sunscreens
    Laura Thomas
    Wayne State University School of Medicine, USA
    J Drugs Dermatol 2:174-7. 2003
  5. ncbi Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005
    Matthew S Goldberg
    Mount Sinai School of Medicine, New York, NY, USA
    J Am Acad Dermatol 57:60-6. 2007
  6. ncbi Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children
    Jessica W Kyle
    ICF International, 1725 Eye St, NW, Suite 1000, Washington, DC, USA
    Pediatrics 121:e1074-84. 2008
  7. ncbi Scientific and regulatory issues related to indoor tanning
    Henry W Lim
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 51:781-4. 2004
  8. ncbi Photoprotection by window glass, automobile glass, and sunglasses
    Chanisada Tuchinda
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 54:845-54. 2006
  9. ncbi 308-nm excimer laser for the treatment of lymphomatoid papulosis and stage IA mycosis fungoides
    Andrew P Kontos
    Photodermatol Photoimmunol Photomed 22:168-71. 2006
  10. ncbi Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis
    Jennifer Rivard
    Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
    J Drugs Dermatol 5:505-10. 2006

Collaborators

Detail Information

Publications28

  1. ncbi Remembrance: Irwin Freedberg
    Henry W Lim
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
    J Invest Dermatol 126:522. 2006
  2. ncbi Sunlight, tanning booths, and vitamin D
    Henry W Lim
    Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 52:868-76. 2005
  3. ncbi Commentary: A responsible approach to maintaining adequate serum vitamin D levels
    Henry W Lim
    Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 57:594-5. 2007
  4. ncbi Sunscreens
    Laura Thomas
    Wayne State University School of Medicine, USA
    J Drugs Dermatol 2:174-7. 2003
  5. ncbi Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005
    Matthew S Goldberg
    Mount Sinai School of Medicine, New York, NY, USA
    J Am Acad Dermatol 57:60-6. 2007
    ....
  6. ncbi Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children
    Jessica W Kyle
    ICF International, 1725 Eye St, NW, Suite 1000, Washington, DC, USA
    Pediatrics 121:e1074-84. 2008
    ..The objectives of this study were to assess the health benefits of the SunWise School Program and use economic analysis to determine the program's net benefits and cost-effectiveness...
  7. ncbi Scientific and regulatory issues related to indoor tanning
    Henry W Lim
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 51:781-4. 2004
  8. ncbi Photoprotection by window glass, automobile glass, and sunglasses
    Chanisada Tuchinda
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 54:845-54. 2006
    ..Factors affecting UV-protective properties of glass are glass type, glass color, interleave between glass, and glass coating. In this article, photoprotection by window glass, automobile glass, and sunglasses is reviewed...
  9. ncbi 308-nm excimer laser for the treatment of lymphomatoid papulosis and stage IA mycosis fungoides
    Andrew P Kontos
    Photodermatol Photoimmunol Photomed 22:168-71. 2006
  10. ncbi Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis
    Jennifer Rivard
    Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
    J Drugs Dermatol 5:505-10. 2006
    ..No dramatic changes in plaque thickness or scaling were seen with either tacrolimus alone or with the combination of tacrolimus and medium dose UVA1 on palmar or plantar psoriasis...
  11. ncbi UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States
    Chanisada Tuchinda
    Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
    Photodermatol Photoimmunol Photomed 22:247-53. 2006
    ..The efficacy and safety of UVA1 (340-400 nm) phototherapy were established by studies from European countries...
  12. ncbi Comparison of broadband UVB, narrowband UVB, broadband UVA and UVA1 on activation of apoptotic pathways in human peripheral blood mononuclear cells
    Chanisada Tuchinda
    Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA
    Photodermatol Photoimmunol Photomed 23:2-9. 2007
    ..The aim of this study is to analyze the effects of different UV wavelengths that are used clinically on normal human peripheral blood mononuclear cells (PBMCs)...
  13. ncbi Photoadaptation of vitiliginous skin to targeted ultraviolet B phototherapy
    Jennifer Rivard
    Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
    Photodermatol Photoimmunol Photomed 23:258-60. 2007
    ..In this pilot study, five patients with Fitzpatrick skin phototypes IV-VI with vitiligo received six treatments of targeted UVB phototherapy over a 3-week period...
  14. ncbi Effects of visible light on the skin
    Bassel H Mahmoud
    Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA
    Photochem Photobiol 84:450-62. 2008
    ..Conversely, because of its cutaneous biologic effects, visible light is used for the treatment of a variety of skin diseases and esthetic conditions in the form of lasers, intense pulsed light and photodynamic therapy...
  15. ncbi Narrowband UVB phototherapy for early-stage mycosis fungoides
    Raechele Cochran Gathers
    Department of Dermatology, Henry Ford Health System, Detroit, MI 48202-2689, USA
    J Am Acad Dermatol 47:191-7. 2002
    ..Upon discontinuation of treatment, 4 patients with CR relapsed, with a mean time to relapse of 12.5 weeks. CONCLUSION: NB-UVB is a viable, comparably safe, and easily administered alternative in the management of early stage MF...
  16. ncbi Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphoma
    Henry K Wong
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
    J Invest Dermatol 126:212-9. 2006
    ..These findings reveal an abnormal regulation of CTLA-4 expression in MF and show that PBMCs from patients with MF have properties that are divergent from those of normal T cells...
  17. ncbi Novel emerging sunscreen technologies
    Chanisada Tuchinda
    Department of Dermatology, Henry Ford Hospital, Detroit, MI 48303, USA
    Dermatol Clin 24:105-17. 2006
    ..With the advances in technologies, many new UV filters have been developed recently. These have improved efficacy and safety. This article reviews these new filters, along with regulatory issues in the United States...
  18. ncbi Polymorphous light eruption in African Americans: pinpoint papular variant
    Andrew P Kontos
    Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA
    Photodermatol Photoimmunol Photomed 18:303-6. 2002
    ..CONCLUSION: Recognition of this pinpoint papular variant of PMLE in dark-skinned individuals is important in the evaluation and management of these patients...
  19. ncbi Classification and evaluation of photodermatoses
    Sharam Samson Yashar
    Department of Dermatology, Henry Ford Health System, Detroit, Michigan 48202, USA
    Dermatol Ther 16:1-7. 2003
    ..Skin biopsies and laboratory investigations, such as antinuclear antibody (ANA) panels and porphyrin profiles, may be required to further confirm the diagnosis...
  20. ncbi Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses
    Sharam Samson Yashar
    Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA
    Photodermatol Photoimmunol Photomed 19:164-8. 2003
    ..Long-term adverse effects and cost-benefit analysis of NB-UVB therapy compared to other treatment modalities remain to be determined...
  21. ncbi Cutaneous diseases in Asians
    Chai Sue Lee
    Department of Dermatology, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202, USA
    Dermatol Clin 21:669-77. 2003
    ..Awareness of these less common cutaneous disorders can be helpful, especially for clinicians who work in areas with a large Asian population...
  22. ncbi UVA-1 as a treatment for scleredema
    Jennifer J Janiga
    Department of Dermatology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA
    Photodermatol Photoimmunol Photomed 20:210-1. 2004
    ..Scleredema is a rare disease that is difficult to treat. Many therapies have been tried with varied and somewhat inconsistent results. Here we report two cases of scleredema successfully treated with low-dose UVA-1...
  23. ncbi Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo
    Prisana Kullavanijaya
    Department of Dermatology, Henry Ford Hospital, 2999 West Grand Boulevard, Detroit, MI 48202, USA
    Photodermatol Photoimmunol Photomed 20:248-51. 2004
    ..No side effects were noted. CONCLUSION: Combination therapy of topical calcipotriene and NB-UVB is a therapeutic option that could be considered in the management of patients with vitiligo...
  24. ncbi Photoprotection by sunscreens with topical antioxidants and systemic antioxidants to reduce sun exposure
    Richard F Edlich
    Plastic Surgical Research Program, University of Virginia Health System, Charlottesville, Virginia, USA
    J Long Term Eff Med Implants 14:317-40. 2004
    ..The Skin Cancer Foundation, the only national and international nonprofit organization concerned exclusively with cancer of the skin, is playing a leadership role in eliminating skin cancer in our world...
  25. ncbi Photoprotection
    Prisana Kullavanijaya
    Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
    J Am Acad Dermatol 52:937-58; quiz 959-62. 2005
    ..All of the above are reviewed in this article. LEARNING OBJECTIVE: At the conclusion of this learning activity, participants should be able to provide an overview of all aspects of photoprotection...
  26. ncbi Transverse melanonychia secondary to total skin electron beam therapy: a report of 3 cases
    Kathryn E Quinlan
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
    J Am Acad Dermatol 53:S112-4. 2005
    ..We report 3 cases of transverse melanonychia secondary to total skin electron beam therapy in patients who were treated for mycosis fungoides...
  27. ncbi Ultraviolet phototherapy for pruritus
    Jennifer Rivard
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
    Dermatol Ther 18:344-54. 2005
    ..Various mechanisms of action for phototherapy have been posited. Treatment limitations, side effects, and common dosing protocols are reviewed...
  28. ncbi Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products
    Camile L Hexsel
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
    J Am Acad Dermatol 59:316-23. 2008
    ..It may be prudent to follow the same approach of our Canadian colleagues of discontinuing combination products until more investigations are available...